ALACHUA, Fla.--(BUSINESS WIRE)--RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a leading global surgical implant company, is pleased to announce that the first human implantation of the company’s map3® Cellular Allogeneic Bone Graft Strips Allograft took place during an anterior lumbar interbody fusion (ALIF) procedure last week. The map3 Strips Allograft implant will expand the company’s current cellular allogeneic bone graft portfolio when it launches later in 2014.
Help employers find you! Check out all the jobs and post your resume.